Trials / Completed
CompletedNCT01235988
Meta-analysis - Eltrombopag
Systematic Review of the Clinical and Cost Effectiveness of Treatments for Idiopathic (Immune) Thrombocytopenic Purpura (ITP): Direct Meta Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the meta-analysis was to explore the efficacy of eltrombopag versus placebo (standard of care)
Detailed description
Meta-analysis of three studies: Bussell 2007 \& Bussell 2009 \& RAISE (TRA102537).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eltrombopag | Eltrombopag 50mg \& standard of care |
| DRUG | Placebo | Placebo + standard of care |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2010-11-08
- Last updated
- 2017-06-07
Source: ClinicalTrials.gov record NCT01235988. Inclusion in this directory is not an endorsement.